Has My GLP-1 Stopped Working — or Is It a Plateau?

Something shifts around month four or five. The appetite suppression that felt almost effortless at the start is quieter now. Food noise — the background hum of cravings and meal-planning that went silent early on — starts to murmur again. The scale, which dropped predictably for weeks, parks itself on the same number for what feels like forever. And the fear arrives: the medication stopped working.

Most of the time, it hasn’t. What you’re feeling is the difference between the dramatic opening chapter of GLP-1 treatment and the steadier middle. Knowing how to tell a true plateau from a normal recalibration is the difference between a calm adjustment and a panicked, counterproductive one.

Why the first few months feel so dramatic

The early weeks on semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) tend to produce the fastest, most visible change — and that sets an expectation the rest of treatment can’t match. Several things happen at once. Appetite suppression is at its most novel, so you’re eating meaningfully less almost overnight. Your stomach empties more slowly, which keeps you full longer. And a portion of that first drop is water and glycogen, not fat — real weight on the scale, but not the kind that keeps falling at the same rate.

The trials show the shape of this curve. In STEP 1, adults on semaglutide 2.4 mg lost about 15% of their body weight — over 68 weeks, not eight. In SURMOUNT-1, tirzepatide produced average losses of roughly 15 to 21% — again, across 72 weeks. The headline numbers are real. The timeline behind them is long, and it is not a straight line.

“Less dramatic” is not the same as “not working”

Here is the piece almost no one explains, and it’s the reason so many people conclude their medication quit: the intense early fullness effect is partly expected to fade, while the medication keeps doing its more important work underneath.

One of the ways these medications create fullness early on is by slowing how fast your stomach empties. Research shows that with continued use of the long-acting GLP-1 medications, that specific stomach-slowing effect tends to attenuate over time — a phenomenon called tachyphylaxis. Reviews of the gastric-emptying data describe exactly this: the slowing is largest after the first doses and diminishes with sustained treatment. The clinically important part is what those same reviews emphasize next — the appetite and weight-management benefits generally persist even as that early stomach-slowing sensation softens.

In plain terms: feeling less dramatically full than you did in month one is often the medication settling into a steady state, not failing. Complete elimination of hunger was never the clinical goal, and it was never the marker of success. A medication that is quietly keeping your appetite manageable while you hold or continue losing is a medication that is working.

A little food noise coming back is normal

Food noise returning at a low volume is not relapse. Hunger cues are supposed to exist; a body with no appetite signaling at all is not the target. What matters is whether that returning hunger is manageable — whether you can still make the choices you want to make — not whether it’s completely absent. If the noise has gone from a roar to an occasional whisper, that’s a body that has adapted, not a treatment that has failed. Learn more about what food noise is and why GLP-1s quiet it.

What actually counts as a plateau

A genuine plateau has a specific shape, and it’s worth defining before you react to one:

Four or more weeks with no meaningful change in weight or measurements
Consistent medication adherence — no missed or late doses skewing the picture
Stable nutrition and activity, not a quietly drifting routine
No constipation or water retention masking fat loss underneath
No new medication, major sleep disruption, or life stressor in the mix

If several of those aren’t true, you may not be looking at a plateau at all — you may be looking at a confounder. Constipation alone can hold two or three pounds on the scale while fat loss continues underneath it. The scale is one signal, and on these medications it is often the noisiest one.

Why plateaus happen — and why they’re physiology, not betrayal

As you lose weight, your body needs fewer calories to run, and it defends its mass with hormonal and metabolic adjustments. A plateau frequently means you’ve reached a new equilibrium at your current dose and intake. That’s expected biology, not a broken system.

A few specific drivers tend to be at work:

Lower body weight means lower energy needs. The deficit that drove early loss shrinks as you get smaller, even if nothing about your eating changed.
Muscle loss can lower your metabolism. Across the trial body-composition data, a meaningful share of weight lost on these medications is lean mass, not fat — and less muscle means fewer calories burned at rest. This is the quiet reason protein and resistance training matter so much.
Appetite suppression softens, which — without attention — can let intake creep up as early side effects fade.
Your habits may not have kept pace with your changing body.

The scale stalling is often the moment these forces come into balance. The response is not automatically “more medication.”

What not to do during a plateau

The instinct at a stall is to do something dramatic. Most of the dramatic options make things worse:

Don’t reflexively push the dose up. Climbing the dose at every stall is how people reach the maximum early, collect side effects, and leave themselves nowhere to go later. Escalation is a clinical decision made when a dose has genuinely stopped working and you’re tolerating it well — not a response to the scale’s schedule.
Don’t crash your intake. Skipping meals or dropping into an aggressive deficit accelerates muscle and bone loss, fatigue, and hair shedding — and undermines the very metabolism you’re trying to support.
Don’t buy “boosters” or gray-market vials online. Compounded and research-grade products carry real dosing-error risk and no FDA review of what’s actually in them. There is no shortcut worth that trade.
Don’t stop suddenly or switch on your own. Both are clinician decisions with real consequences for regain and returning side effects.

How to read a plateau before you react to it

Before changing anything, run an honest audit — the same one we run with our own patients:

Protein. Are you actually clearing roughly 30 grams of quality protein at two to three meals? Muscle is preserved in pulses, meal by meal, not by a daily total you technically hit only at dinner. Distribution is the lever most people never hear about.
Resistance training. Still happening two to three times a week, or quietly dropped when life got busy?
Portion creep. As early side effects fade, intake tends to rise without anyone deciding it should.
Sleep, stress, hydration, alcohol. The multipliers that undo good habits the moment they slip.
Non-scale progress. Is your waist still shrinking or your strength still climbing? A stalled scale next to a shrinking waist is not a plateau — it’s body recomposition, and it’s a win. For more, see why eating even less can stall fat loss on a GLP-1.

How Nuu Metabolic troubleshoots a plateau

A plateau is exactly the moment a passive prescription clinic leaves you alone — and exactly the moment structured support earns its place. This is the work: reading why the scale stopped before deciding what to do about it.

Nuu Rx provides brand-name GLP-1 prescription management for eligible adults in Illinois, with medical oversight and dose decisions made deliberately rather than on autopilot. Nuu Total adds the metabolic layer most plateaus actually need — protein strategy, muscle-preservation guidance, and plateau troubleshooting built around your own numbers. And The GLP-1 Optimization Guide is the roadmap behind all of it, written to help you understand what your body is doing before, during, and after a stall.

A note from Urooj Mujtaba, PA-C. In fifteen years of emergency medicine, I learned to tell the difference between a symptom that needs action right now and one that needs patience and a plan. A plateau is almost always the second kind. The people who get the most from these medications show up with numbers — percent loss, protein average, a strength marker — instead of impressions. Bring the data, and a stall becomes a solvable problem instead of a frightening one.

When to contact a clinician

A plateau itself is not urgent. But contact your prescriber promptly for repeated vomiting or an inability to keep fluids down, severe or persistent abdominal pain (especially radiating to the back), no stool or gas with a swollen painful belly, fainting or confusion, or any symptom that feels urgent. Rapid loss with weakness or dizziness is also a reason to call — not to push harder.

Frequently asked questions

How long can a normal plateau last? Weeks is common; sometimes longer. A stall of four-plus weeks with stable habits is worth auditing, but it isn’t automatically a problem — especially if your waist or strength is still moving.

Does a plateau mean I need a higher dose? Not by itself. A dose increase is appropriate when a dose has genuinely stopped working and you’re tolerating it well — a clinical judgment, not a reaction to the scale.

My appetite came back — did I build a tolerance? The stomach-slowing effect that drives early fullness does tend to soften over time, but the appetite and weight benefits generally persist. Returning hunger that stays manageable is expected, not failure.

Should I switch medications? Sometimes switching is reasonable — for intolerable side effects, a true non-response, or coverage loss — but it means re-titrating from a lower dose and is a clinician-led decision. Bring your tracker, not just your frustration. Read our full guide to switching from semaglutide to tirzepatide.

Ready for a more structured GLP-1 plan? Nuu Metabolic offers brand-name GLP-1 prescription management for eligible adults in Illinois, plus a comprehensive GLP-1 optimization guide covering nutrition, side effects, plateaus, muscle preservation, and long-term maintenance. Whether you need medical oversight, a clearer roadmap, or both, the goal is to help you stop guessing and start navigating treatment with confidence.

Explore Nuu Rx · Get the GLP-1 Guide · Schedule Your Appointment

Educational only. Not medical advice. Prescription treatment is not guaranteed and depends on clinical eligibility, medical history, safety screening, and provider judgment. Medication cost, labs, copays, and pharmacy fees are separate. Clinical services are available only to eligible adults located in Illinois.

Sources. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989. · Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205. · Review of delayed gastric emptying and tachyphylaxis with GLP-1 receptor agonists and tirzepatide, The Journal of Clinical Endocrinology & Metabolism, 2024 (gastric-emptying slowing attenuates over time while weight and glycemic benefits persist).

Has My GLP-1 Stopped Working — or Is This Just a Plateau?